Business description: Nectar Lifesciences Limited

Nectar Lifesciences Limited is an India-based pharmaceutical company. The Company's business areas include active pharmaceutical ingredients (APIs) and intermediates, formulations/finished dosage formulations (FDF), menthol and mint derivatives, and empty hard gelatin capsules. The Company is engaged in the manufacturing of oral and sterile cephalosporin products. Its oral cephalosporins include cefixime, cefurozime axetil crystalline, cefuroxime axetil amorphous, cedpodoxime proxetil, cefprozil and cefdinir. Its sterile cephalosporins include cefotaxime sodium, ceftriaxone sodium, cefuroxime sodium, cefazolin sodium, ceftazidime pentahydrate and cefepime arginine. Its capacities include cefixime, cefuroxime axetil amorphous, cefuroxime axetil crystalline, cefotaxime sodium and ceftriaxone sodium. The Company offers contract manufacturing capabilities for solid dosage forms, such as tablets, capsules, dry powder oral suspension and granules and injectable for cephalosporins.

Number of employees: 1,786

Sales by Activity: Nectar Lifesciences Limited

Fiscal Period: March 2021 (INR) 2022 (INR) 2023 (INR) 2024 (INR) 2025 (INR)

Pharmaceuticals Products

15.43B 16.69B 15.24B 16.85B 16.7B

Geographical breakdown of sales: Nectar Lifesciences Limited

Fiscal Period: March 2021 (INR) 2022 (INR) 2023 (INR) 2024 (INR) 2025 (INR)

India

9.66B 11.81B 8.45B 11.46B 11.72B

Outside India

7.98B 7.45B 9.01B 7.79B 7.37B

Executive Committee: Nectar Lifesciences Limited

Manager TitleAgeSince
Director of Finance/CFO 68 2022-11-13
Compliance Officer - 2025-03-31

Composition of the Board of Directors: Nectar Lifesciences Limited

Director TitleAgeSince
Chairman 66 1995-06-26
Director/Board Member 69 2019-02-10
Director/Board Member 75 2021-09-20
Director/Board Member 61 2022-08-01
Director/Board Member 49 2025-05-31

Shareholders: Nectar Lifesciences Limited

NameStocks%Valuation
28.75 %
55,845,600 28.75 % 7 M ₹
22.46 %
43,622,400 22.46 % 5 M ₹
2.051 %
3,984,829 2.051 % 490 413 ₹
0.6375 %
1,238,448 0.6375 % 152 416 ₹
Government of India
0.0687 %
133,413 0.0687 % 16 419 ₹

Company details: Nectar Lifesciences Limited

Nectar Lifesciences Ltd.

SCO 38-39, Madhya Marg

160009, Chandigarh

+

http://www.neclife.com
address Nectar Lifesciences Limited(NECLIFE)

Generic Pharmaceuticals

Change 5-day change 1-year change 3-year change Capi.($)
-1.80%-4.60%-41.07%-51.93% 21.24M
+0.57%+0.13%+16.45%+78.10% 48.31B
-0.50%-0.41%+67.13%+107.90% 35.33B
-1.56%-3.13%-4.88%+32.80% 11.85B
-1.11%-3.73%+16.41%+81.64% 11.64B
-0.37%-0.19%+36.48%+136.73% 8.99B
-0.27%+0.42%+51.66%-6.22% 6.93B
-0.77%-3.00%+13.55%+32.01% 6.72B
+0.24%-4.02%+2.19%+192.78% 6.43B
+1.60%-9.55%-30.77%+8.47% 5.66B
Average -0.40%-1.85%+12.71%+61.23% 14.19B
Weighted average by Cap. -0.15%-0.93%+27.59%+81.84%
  1. Stock Market
  2. Stocks
  3. NECLIFE Stock
  4. Company Nectar Lifesciences Limited